|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0033235,
umls-concept:C0036525,
umls-concept:C0041455,
umls-concept:C0057455,
umls-concept:C0072052,
umls-concept:C0229671,
umls-concept:C0262950,
umls-concept:C0332307,
umls-concept:C0439849,
umls-concept:C0439861,
umls-concept:C0441889,
umls-concept:C0445223,
umls-concept:C0600139,
umls-concept:C1522484,
umls-concept:C1524119,
umls-concept:C1552599,
umls-concept:C1704787,
umls-concept:C1709708,
umls-concept:C2603343,
umls-concept:C2745888
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1998-7-9
|
|
pubmed:abstractText |
To investigate if serum levels of carboxyterminal propeptide of type I procollagen (PICP), cross-linked carboxyterminal telopeptide of type I collagen (ICTP) and urinary levels of deoxypyridinoline (D-Pyr) are useful markers of bone metastasis in patients with prostate carcinoma, we measured these markers in patients with untreated benign prostatic hyperplasia (BPH) and untreated prostate carcinoma (PCA).
|
|
pubmed:language |
jpn
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Amino Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Collagen,
http://linkedlifedata.com/resource/pubmed/chemical/Collagen Type I,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides,
http://linkedlifedata.com/resource/pubmed/chemical/Procollagen,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological,
http://linkedlifedata.com/resource/pubmed/chemical/collagen type I trimeric...,
http://linkedlifedata.com/resource/pubmed/chemical/deoxypyridinoline,
http://linkedlifedata.com/resource/pubmed/chemical/procollagen type I carboxy...
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0021-5287
|
|
pubmed:author |
pubmed-author:AraiKK,
pubmed-author:AraiTT,
pubmed-author:HondaMM,
pubmed-author:HosoyaYY,
pubmed-author:ImaiTT,
pubmed-author:KofuKK,
pubmed-author:MaedaSS,
pubmed-author:ROPEE ZEZ,
pubmed-author:UmedaHH,
pubmed-author:YanoMM,
pubmed-author:YoshidaKK
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
89
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
484-91
|
|
pubmed:dateRevised |
2011-7-28
|
|
pubmed:meshHeading |
pubmed-meshheading:9597867-Aged,
pubmed-meshheading:9597867-Aged, 80 and over,
pubmed-meshheading:9597867-Amino Acids,
pubmed-meshheading:9597867-Bone Neoplasms,
pubmed-meshheading:9597867-Collagen,
pubmed-meshheading:9597867-Collagen Type I,
pubmed-meshheading:9597867-Humans,
pubmed-meshheading:9597867-Male,
pubmed-meshheading:9597867-Middle Aged,
pubmed-meshheading:9597867-Peptide Fragments,
pubmed-meshheading:9597867-Peptides,
pubmed-meshheading:9597867-Procollagen,
pubmed-meshheading:9597867-Prostatic Neoplasms,
pubmed-meshheading:9597867-Tumor Markers, Biological
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
[Studies of type I collagen related substances as bone metastatic markers of prostate carcinoma with special regard to serum carboxyterminal propeptide of type. I. Procollagen (PICP), cross-linked carboxyterminal telopeptide of type I collagen (ICTP) and Urinary deoxypyridinoline levels].
|
|
pubmed:affiliation |
Department of Urology, Dokkyo University School of Medicine.
|
|
pubmed:publicationType |
Journal Article,
English Abstract
|
